Brooklyn Immunotherapeutics Inc (NQ: BTX )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 14, 2022 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
March 21, 2012
Form 8-K
Source: SEC/Edgar
March 20, 2012
Form 8-K
Source: SEC/Edgar
March 13, 2012
Form 8-K
Source: SEC/Edgar
March 08, 2012
Form 8-K
Source: SEC/Edgar
February 16, 2012
Form 8-K
Source: SEC/Edgar
January 23, 2012
Form 8-K
Source: SEC/Edgar
January 02, 2012
Form 8-K
Source: SEC/Edgar
December 20, 2011
Form 8-K
Source: SEC/Edgar
December 15, 2011
Form 8-K
Source: SEC/Edgar
December 11, 2011
Form CT ORDER
Source: SEC/Edgar
November 30, 2011
Form 8-K
Source: SEC/Edgar
November 28, 2011
Form 8-K
Source: SEC/Edgar
November 13, 2011
Form 8-K
Source: SEC/Edgar
November 07, 2011
Form 8-K
Source: SEC/Edgar
October 24, 2011
Form 8-K
Source: SEC/Edgar
October 19, 2011
Form 8-K
Source: SEC/Edgar
October 12, 2011
Form 8-K
Source: SEC/Edgar
October 10, 2011
Form 8-K
Source: SEC/Edgar
October 03, 2011
Form 8-K
Source: SEC/Edgar
September 11, 2011
Form 8-K
Source: SEC/Edgar
September 05, 2011
Form SC 13D/A
Source: SEC/Edgar
August 24, 2011
Form 8-K
Source: SEC/Edgar
August 23, 2011
Form 8-K
Source: SEC/Edgar
August 18, 2011
Form 8-K
Source: SEC/Edgar
August 09, 2011
Form 8-K
Source: SEC/Edgar
July 18, 2011
Form EFFECT
Source: SEC/Edgar
July 14, 2011
Form EFFECT
Source: SEC/Edgar
July 14, 2011
Form 8-K
Source: SEC/Edgar
July 14, 2011
Form CT ORDER
Source: SEC/Edgar
July 07, 2011
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.